Abstracts for Tuesday

time

Tuesday February 6, 2001

8:30- 9:00 am

 

State-of-the-Art Lecture Session 30. Molecular Trickery on the HIV-Host Cell Battlefield <8:30- 9:00 am, Ballroom I-X>

9:00- 9:30 am

 

State-of-the-Art Lecture 31. HIV-Related Peripheral Neuropathies and Their Treatment <9:00- 9:30 am, Ballroom I-X>

 

10:00 am-12:30 pm

Slide Session 32. Epidemiology and Infection Control (abstracts 261-268B) <10 am-12:15 pm, Ballroom I-V>

Slide Session 33. Immunology (abstracts 269-278) <10 am-12:30 pm, Ballroom VI-VII>

Slide Session 34. Developments in Virology (abstracts 279-287) <10 am-12:15 pm, Ballroom VIII-X>

 

2-4 pm

Symposium Session 35. HIV Virion Morphogenesis and Release (abstracts S9 - S11) <2-4 pm, Ballroom I-III>

Symposium Session 36: Maternal-Fetal Transmission of HIV-1: Implications for Care of HIV-Affected Women and Children
(abstracts S12 - S15) <2-4 pm, Ballroom VIII-X>

Slide Session 37. Structured Treatment Interruption: Novel Strategy or Oxymoron (abstracts 288-293) <2-4 pm, Ballroom IV-VII>

 

4:30-6:30 pm

Poster Session 38. Trends in Morbidity and Mortality (abstracts 294-300) <Tuesday, 4:30-6:30 pm>
Poster Session 39. Antiretroviral Chemotherapeutic Agents: Preclinical Studies (abstracts 301-313) <Tuesday, 4:30-6:30 pm>
Poster Session 40. Clinical Trials of HIV-1 Reverse Transcriptase Inhibitors (abstracts 314-327) <Tuesday, 4:30-6:30 pm>
Poster Session 41. Clinical Trials of HIV-1 Protease Inhibitors (abstracts 328-339) <Tuesday, 4:30-6:30 pm>
Poster Session 42. Antiretroviral Chemotherapy: When to Start (abstracts 340-342) <Tuesday, 4:30-6:30 pm>
Poster Session 43. Immune Based Therapy (abstracts 343-353) <Tuesday, 4:30-6:30 pm>
Poster Session 44. Treatment Interruption (abstracts 354-365) <Tuesday, 4:30-6:30 pm>
Poster Session 45. Immune Reconstitution (abstracts 366-382) <Tuesday, 4:30-6:30 pm>
Poster Session 46. Viral Dynamics and Reservoirs (abstracts 383-399) <Tuesday, 4:30-6:30 pm>
Poster Session 47. Treatment of Primary Infection (abstracts 400-410) <Tuesday, 4:30-6:30 pm>
Poster Session 48. Clinical, Viral, and Immunological Features of Primary Infection (abstracts 411-422)<Tuesday, 4:30-6:30 pm>
Poster Session 49. Drug Resistance in Primary Infection (abstracts 423-427) <Tuesday, 4:30-6:30 pm>
Poster Session 50. Regimen Failure (abstracts 428-432) <Tuesday, 4:30-6:30 pm>
Poster Session 51. Clinical Utility of Resistance Testing (abstracts 433-441) <Tuesday, 4:30-6:30 pm>
Poster Session 52. Resistance to Antiretroviral Drugs (abstracts 442-475) <Tuesday, 4:30-6:30 pm>
Poster Session 53. Adherence to Therapy and Retention in Clinical Trials (abstracts 476-486) <Tuesday, 4:30-6:30 pm>
Poster Session 54. HIV Care in Special Settings (abstracts 487-496) <Tuesday, 4:30-6:30 pm>
Poster Session 55. Antiretroviral Chemotherapy: Miscellaneous Issues (abstracts 497-498) <Tuesday, 4:30-6:30 pm>

4:30-5:45 pm

Slide Session 56. HIV Pathogenesis (abstracts 499-508) <4:30-7 pm, Ballroom IV-VII>